Concepedia

Publication | Open Access

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

66

Citations

77

References

2022

Year

References

YearCitations

Page 1